IL6 and metabolic dysfunction-associated steatotic liver disease: In addition, because of the budget limitations, we could not assess other biomarkers of systemic inflammation including interleukin 1(IL-1) and IL-6 as well as the biomarkers of oxidative stress such as catalase and superoxide dismutase in NAFLD patients.